ORTHOPEDIATRICS CORP (KIDS)
Health Care · Medical Devices · NASDAQ
OrthoPediatrics is a pediatric orthopedic device maker providing anatomically-tailored implants, instruments, and conservative treatment solutions designed specifically for children, with an expanding network of O&P clinics.
What ORTHOPEDIATRICS CORP does
OrthoPediatrics Corp. designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces specifically for children with orthopedic conditions. The company sells branded products including PediLoc, PediPlates, cannulated screws, intramedullary nails, ACL reconstruction systems, spine devices, and pediatric bracing products to hospitals and medical facilities across the United States and international markets. The company also operates orthotic and prosthetic clinics delivering pediatric non-surgical treatment through its Boston O&P subsidiary and international clinic acquisitions.
Themes: pediatric orthopedics, orthotics and prosthetics, spine deformity correction, medical implants, surgical navigation
Fundamentals
- Price$25.65 as of 2026-08-21 close
- Market cap$670M as of 2026-08-21
- 1-year return+33.9% 2025-08-21 close $19.15 → 2026-08-21 close $25.65
- P/En/a negative earnings
- Net margin-15.7% as of 2026-08-24
- Gross margin+73.7% as of 2026-08-24
- ROE-11.5% as of 2026-08-24
- Debt / equity0.29 as of 2026-08-24
- Revenue growth (YoY)+14.5% as of 2026-08-24
- Revenue CAGR (3y)+24.6% SEC XBRL
- Beta1.02 as of 2026-08-24
- Last reported earnings2026-08-04 SEC EDGAR Form 8-K (Item 2.02)
How KIDS compares in its sector
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which KIDS reported a dividend payment is FY2017, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2017 ratio would not describe KIDS today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2017) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
How ORTHOPEDIATRICS CORP looks technically
ORTHOPEDIATRICS CORP (KIDS) is trading 41.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 36 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 72, in overbought territory (above 70). It made a new 20-day high about 3 trading days ago. It is 4.1% below its 52-week high (its highest price of the past year).
Trend
8
| Distance from the 200-day | it is trading 41.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +41.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $20.79 | $20.79 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $18.17 | $18.17 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 28 calendar days ago — the swings before that are what the structure reading is measured on | 28 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 18.1. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 36 trading days ago — a "golden cross", a bullish long-term signal | 36 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control | 41.1 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 72, in overbought territory (above 70) | 72.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($20.48 to $26.74) — its "stochastic" reading is 83 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 82.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 15 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $26.74 | $26.74 |
|---|---|---|
| From the 52-week high | it is 4.1% below its 52-week high (its highest price of the past year) | -4.1% |
| Above the 52-week low | it is 77.9% above its 52-week low (its lowest price of the past year) | +77.9% |
| Below the 52-week high | it is 4.1% below its highest point of the past year | 4.1% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $73.91 (set on 2021-11-05) | $73.91 |
| Given back of the 52-week move | over the past year its closes ranged ($14.64 to $26.50), and it has given back only a small part of its rise from last year’s low — 7% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $18.79 to $19.17. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 7.2% |
| From the all-time high | it is 65.3% below its all-time high | -65.3% |
| Nearest price level | it is trading 1.0% above a support level at $25.41 — a price it turned at twice since 2024-10-29, most recently on 2025-02-14. Since 2024-08-21 it has 11 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.0% |
| All-time low | its lowest closing price on record is $14.00 (set on 2018-04-03) | $14.00 |
| Above the all-time low | it is 83.2% above its all-time low | +83.2% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 96% of the past ~6 months) | 96th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.01 between its high and its low — about 3.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.01 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $18.41 and $27.63 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $18.41 – $23.02 – $27.63 |
| Typical daily range (% of price) | its price moves about 3.9% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.9% |
| Stretch from the 200-day average | it is trading 7.4 daily ranges above its 200-day average price (41.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.72× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
3
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|---|---|
| Since a bullish engulfing | 9 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 9 sessions ago |
| Since a bearish engulfing | today it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | today |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|---|---|
| Open gap | it gapped 6.6% above the previous close 51 sessions ago and has not traded back through the level it left behind at 16.92 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +6.6% |
| Gap filled | a 5.8% gap up opened on 2026-08-05 has been "filled" 12 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 12 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -3.21% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 29.3 percentage points (the stock gained 31.6% while the market gained 2.3%) | +29.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 36.1 percentage points (the stock gained 39.2% while the market gained 3.1%) | +36.1% |
| vs market, 6 months | over the past 6 months this stock beat the market by 40.2 percentage points (the stock gained 51.2% while the market gained 11.1%) | +40.2% |
| vs market, 12 months | over the past 12 months this stock beat the market by 13.5 percentage points (the stock gained 33.9% while the market gained 20.5%) | +13.5% |
Signal agreement
2
| Bullish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: its RSI momentum gauge is overbought (a stretched reading), near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 30% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 7.2% of the share price. | +29.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 36% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $18.80 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +36.4% |
|---|---|---|
| Vs the average paid since it last reported | the price is 7% above the average price paid since it last reported on 2026-08-04 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $24.05 — a volume-weighted average of daily closes over 14 sessions, not a true tick-by-tick VWAP. | +6.6% |
Price levels it has turned at before
KIDS last closed at $25.65 on 2026-08-21. Since 2024-08-21 it has turned at 11 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $25.41 | Support | 1.0% below the last close | turned there twice · 2024-10-29 to 2025-02-14 |
| $26.23 | Resistance | 2.3% above the last close | turned there three times · 2025-03-13 to 2025-04-02 |
| $27.43 | Resistance | 6.9% above the last close | turned there three times · 2024-11-25 to 2025-01-21 |
| $23.80 | Support | 7.2% below the last close | turned there three times · 2024-10-10 to 2025-07-24 |
| $22.37 | Support | 12.8% below the last close | turned there five times · 2024-11-15 to 2025-06-12 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $18.10.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $23.11 and $26.21 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $18.10.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Overbought (14-day RSI above 70) · Broke out to a new 20-day high · in a strong, established uptrend (ADX) · beating the market · Printed a bearish engulfing pair | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$26.67 range $22.00 – $35.00; median $25.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for KIDS
- Consensus EPS estimate-$0.215 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["History of operating losses and uncertainty regarding future profitability.","Substantial dependence on intellectual property protection and potential for IP infringement claims.","Regulatory and compliance risks associated with medical device manufacturing and international distribution."]
What changed in the latest 10-Q
AI-assisted comparison of KIDS's 10-Q filed 2026-05-01 against the prior one filed 2025-10-29.
Management's Discussion & Analysis (MD&A)
- Added:
- New 10-K filing date reference: March 4, 2026 (in newer filing)
- Statement that in 2025, Company opened a warehouse in the Netherlands (newer filing)
- Statement that in November 2025, Company established a legal entity in Brazil to sell and distribute directly to the local market (newer filing)
- Reference to adjustments to revenue related to finalization of payer reimbursement rates applicable to prior-period services during 2026 (newer filing)
- Statement that for the three months ended March 31, 2026, consignment sales accounted for approximately 60% of total net sales (newer filing)
- Removed:
- Statement that Company opened warehouse in Netherlands in 2025 (removed from warehouse opening sentence in newer filing, relocated to separate sentence)
- Reference to nine months ended September 30, 2025, with consignment sales at approximately 70% (older filing only)
- Reworded:
- Number of O&P clinics changed from 'approximately 40' to 'over 50' (newer filing)
- Number of surgical and specialized bracing systems changed from '82' to 'nearly 90' (newer filing)
- Number of independent sales agencies changed from 'over 40' to 'over 30' (newer filing)
- Number of sales representatives changed from '235' to '230' (newer filing)
- Number of children impacted changed from '1,254,000' to '1,336,000' (newer filing)
- Warehouse opening statement restructured: older filing states 'opened warehouses in Germany and Australia in 2024 and the Netherlands in 2025'; newer filing states 'opened warehouses in Germany and Australia in 2024. In 2025, we opened a warehouse in the Netherlands' (newer filing)
- Prior 10-K filing date reference changed from 'March 5, 2025' to 'March 4, 2026' (newer filing)
- Notes:
- Older filing text appears truncated at end of social impact section; comparison limited to available text
- Consignment sales percentages reflect different periods (3 months vs. 9 months) making direct comparison not meaningful
- The removal of Netherlands warehouse opening from the consolidated sentence and addition as separate sentence reflects restructuring rather than substantive change
Risk Factors
- Added:
- Newer filing dated 2026-05-01 references Form 10-K filed on March 4, 2026
- Newer filing contains Q1 2026 financial data (three months ended March 31, 2026)
- Newer filing shows cash balance of $12,193 thousand as of March 31, 2026
- Newer filing shows goodwill of $115,173 thousand as of March 31, 2026
- Removed:
- Older filing dated 2025-10-29 referenced Form 10-K filed on March 5, 2025
- Older filing contained Q3 2025 financial data (three and nine months ended September 30, 2025)
- Older filing contained nine-month comparative financial statements for 2025 and 2024
- Older filing showed cash balance of $16,826 thousand as of September 30, 2025
- Older filing showed goodwill of $103,613 thousand as of September 30, 2025
- Older filing included intangible asset impairment charge of $2,268 thousand in operating expenses
- Older filing included restructuring charges of $2,294 thousand in three-month period and $5,305 thousand in nine-month period
- Older filing included loss on early extinguishment of debt line item
- Reworded:
- Item page numbers changed: Risk Factors from page 37 to page 33; Unregistered Sales from page 38 to page 33; other items adjusted accordingly
- Statements of Operations changed from presenting both three-month and nine-month periods to presenting only three-month period
- Statements of Comprehensive Loss changed from presenting both three-month and nine-month periods to presenting only three-month period
- Balance sheet comparison dates changed from September 30, 2025 and December 31, 2024 to March 31, 2026 and December 31, 2025
- Stockholders' Equity statement changed from nine-month period presentation to three-month period presentation
- Notes:
- This comparison reflects the routine updating of quarterly financial information across different reporting periods (Q3 2025 vs. Q1 2026) rather than substantive changes to the Risk Factors section itself
- The forward-looking statements section remains substantially identical between filings with only the Form 10-K filing date updated
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 1 sell ($148281) — 1 selling insider
Most recent open-market transaction: 2026-03-16. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about KIDS's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding KIDS as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 1,774,866
- Reported value $28,167,127
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
KIDS had 839,134 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
KIDS had 3.21% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.9 days to cover at the same settlement.
- Reported short interest (shares) 839,134
- Short interest (% of shares outstanding) 3.21%
- Prior settlement (shares) 881,263
- Reported change -4.78%
- Days to cover (reported) 5.9
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Medtronic (MDT)
- Stryker (SYK)
- Zimmer Biomet (ZBH)
- Johnson & Johnson (JNJ)
- NuVasive (NUVA)
- Globus Medical (GMED)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare KIDS vs…
Frequently asked questions
What does ORTHOPEDIATRICS CORP (KIDS) do?
OrthoPediatrics Corp. designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces specifically for children with orthopedic conditions. The company sells branded products including PediLoc, PediPlates, cannulated screws, intramedullary nails, ACL reconstruction systems, spine devices, and pediatric bracing products to hospitals and medical facilities across the United States and international markets.
What sector is ORTHOPEDIATRICS CORP (KIDS) in?
ORTHOPEDIATRICS CORP (KIDS) is classified in the Health Care sector. Its industry is Medical Devices. It trades on NASDAQ.
Who are ORTHOPEDIATRICS CORP's (KIDS) competitors?
Notable peers of ORTHOPEDIATRICS CORP (KIDS) include Medtronic, Stryker, Zimmer Biomet, Johnson & Johnson and NuVasive. This peer set is informational only — not financial advice.
Is ORTHOPEDIATRICS CORP (KIDS) overbought or oversold right now?
ORTHOPEDIATRICS CORP (KIDS) is currently in overbought territory (its 14-day RSI is 72, above 70) (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on KIDS come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.